Ludolph, Albert C. 1953-
Ludolph, Albert
VIAF ID: 311118040 ( Personal )
Permalink: http://viaf.org/viaf/311118040
Preferred Forms
-
- 100 1 _ ‡a Ludolph, Albert C. ‡d 1953-
4xx's: Alternate Name Forms (5)
5xx's: Related Names (5)
- 551 _ _ ‡a Bad Pyrmont ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 500 1 _ ‡a Ludolph, Andrea ‡d 1962-2015 ‡4 bezf ‡4 https://d-nb.info/standards/elementset/gnd#familialRelationship ‡e Beziehung familiaer
- 551 _ _ ‡a Ulm ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Universität Mainz ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Universitätsklinikum Ulm ‡b Klinik für Neurologie ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
"Anästhesie" - Vorerfahrungen, Sachwissen, Befürchtungen, Informationsbedürfnis : (Eine Repräsentativumfrage in der Mainzer Bevölkerung) | |
Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy | |
Grundlagen der klinischen Neuroprotektion | |
In vivo protein complementation demonstrates presynaptic α-Synuclein oligomerization and age-dependent accumulation of 8–16-mer oligomer species | |
MR-imaging pattern is not a predictor of occult atrial fibrillation in patients with cryptogenic stroke | |
Oligoklonale Immunglobulin G Banden im Blutserum nach diagnostischer Liquorpunktion | |
Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis | |
Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting | |
Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany | |
Status of clinical research in neurology in Germany - a national survey | |
tödliche Massenblutung im Nierenlager und ihre anatomische Grundlage | |
Treatment of amyotrophic lateral sclerosis insoghts into the future ; satellite symposium held during the Tenth Meeting of the European Neurological Society, 20. June, 2000, Jerusalem, Israel |